Literature DB >> 30152888

Cerebrospinal fluid vasopressin and symptom severity in children with autism.

Ozge Oztan1, Joseph P Garner1,2, Sonia Partap3, Elliott H Sherr4, Antonio Y Hardan1, Cristan Farmer5, Audrey Thurm5, Susan E Swedo5, Karen J Parker1.   

Abstract

Autism is a brain disorder characterized by social impairments. Progress in understanding autism has been hindered by difficulty in obtaining brain-relevant tissues (eg, cerebrospinal fluid [CSF]) by which to identify markers of disease and targets for treatment. Here, we overcome this barrier by providing evidence that mean CSF concentration of the "social" neuropeptide arginine vasopressin (AVP) is lower in children with autism versus controls. CSF AVP concentration also significantly differentiates individual cases from controls and is associated with greater social symptom severity in children with autism. These findings indicate that AVP may be a promising CSF marker of autism's social deficits. Ann Neurol 2018;84:611-615. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30152888      PMCID: PMC6719782          DOI: 10.1002/ana.25314

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Being human: love: neuroscience reveals all.

Authors:  Larry J Young
Journal:  Nature       Date:  2009-01-08       Impact factor: 49.962

Review 2.  Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic.

Authors:  C Sue Carter; Ericka M Boone; Hossein Pournajafi-Nazarloo; Karen L Bales
Journal:  Dev Neurosci       Date:  2009-06-17       Impact factor: 2.984

3.  Standardizing ADOS domain scores: separating severity of social affect and restricted and repetitive behaviors.

Authors:  Vanessa Hus; Katherine Gotham; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2014-10

4.  Central vasopressin administration regulates the onset of facultative paternal behavior in microtus pennsylvanicus (meadow voles).

Authors:  K J Parker; T M Lee
Journal:  Horm Behav       Date:  2001-06       Impact factor: 3.587

Review 5.  Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.

Authors:  Brit Fitzner; Michael Hecker; Uwe Klaus Zettl
Journal:  Autoimmun Rev       Date:  2015-06-10       Impact factor: 9.754

6.  An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.

Authors:  Hamid Meziane; Fabienne Schaller; Sylvian Bauer; Claude Villard; Valery Matarazzo; Fabrice Riet; Gilles Guillon; Daniel Lafitte; Michel G Desarmenien; Maithé Tauber; Françoise Muscatelli
Journal:  Biol Psychiatry       Date:  2014-11-20       Impact factor: 13.382

7.  Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.

Authors:  Olga Peñagarikano; María T Lázaro; Xiao-Hong Lu; Aaron Gordon; Hongmei Dong; Hoa A Lam; Elior Peles; Nigel T Maidment; Niall P Murphy; X William Yang; Peyman Golshani; Daniel H Geschwind
Journal:  Sci Transl Med       Date:  2015-01-21       Impact factor: 17.956

Review 8.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

Review 9.  Oxytocin, vasopressin, and the neurogenetics of sociality.

Authors:  Zoe R Donaldson; Larry J Young
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

10.  Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.

Authors:  Dean S Carson; Joseph P Garner; Shellie A Hyde; Robin A Libove; Sean W Berquist; Kirsten B Hornbeak; Lisa P Jackson; Raena D Sumiyoshi; Christopher L Howerton; Sadie L Hannah; Sonia Partap; Jennifer M Phillips; Antonio Y Hardan; Karen J Parker
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

View more
  16 in total

1.  Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder.

Authors:  Ozge Oztan; Joseph P Garner; John N Constantino; Karen J Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

Review 2.  Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities.

Authors:  Nicole Rigney; Geert J de Vries; Aras Petrulis; Larry J Young
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

Review 3.  Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors:  Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

4.  A Psychometrically Robust Screening Tool To Rapidly Identify Socially Impaired Monkeys In The General Population.

Authors:  Catherine F Talbot; Joseph P Garner; Alyssa C Maness; Brenda McCowan; John P Capitanio; Karen J Parker
Journal:  Autism Res       Date:  2020-07-17       Impact factor: 5.216

5.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

6.  Assessment of medical morbidities in a rhesus monkey model of naturally occurring low sociality.

Authors:  Adam K Myers; Catherine F Talbot; Laura A Del Rosso; Alyssa C Maness; Sierra M V Simmons; Joseph P Garner; John P Capitanio; Karen J Parker
Journal:  Autism Res       Date:  2021-04-12       Impact factor: 5.216

7.  Arginine Vasopressin-Containing Neurons of the Suprachiasmatic Nucleus Project to CSF.

Authors:  Alana Taub; Yvette Carbajal; Kania Rimu; Rebecca Holt; Yifan Yao; Amanda L Hernandez; Joseph LeSauter; Rae Silver
Journal:  eNeuro       Date:  2021-04-16

Review 8.  The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder.

Authors:  Amelie M Borie; Constantina Theofanopoulou; Elissar Andari
Journal:  Handb Clin Neurol       Date:  2021

9.  Autism-associated biomarkers: test-retest reliability and relationship to quantitative social trait variation in rhesus monkeys.

Authors:  Ozge Oztan; Catherine F Talbot; Emanuela Argilli; Alyssa C Maness; Sierra M Simmons; Noreen Mohsin; Laura A Del Rosso; Joseph P Garner; Elliott H Sherr; John P Capitanio; Karen J Parker
Journal:  Mol Autism       Date:  2021-07-08       Impact factor: 6.476

Review 10.  Is Oxytocin "Nature's Medicine"?

Authors:  C Sue Carter; William M Kenkel; Evan L MacLean; Steven R Wilson; Allison M Perkeybile; Jason R Yee; Craig F Ferris; Hossein P Nazarloo; Stephen W Porges; John M Davis; Jessica J Connelly; Marcy A Kingsbury
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.